O
OrbiMed’s Neurocrine Biosciences NBIX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $55.1M | Sell |
438,540
-496,100
| -53% | -$62.4M | 1.38% | 21 |
|
|
2025
Q1 | $103M | Sell |
934,640
-3,480
| -0.4% | -$385K | 2.46% | 12 |
|
|
2024
Q4 | $128M | Buy |
938,120
+635,900
| +210% | +$86.8M | 2.63% | 7 |
|
|
2024
Q3 | $34.8M | Sell |
302,220
-145,980
| -33% | -$16.8M | 0.63% | 48 |
|
|
2024
Q2 | $61.7M | Buy |
448,200
+25,100
| +6% | +$3.46M | 1.22% | 23 |
|
|
2024
Q1 | $58.4M | Sell |
423,100
-96,179
| -19% | -$13.3M | 1.07% | 31 |
|
|
2023
Q4 | $68.4M | Buy |
519,279
+103,379
| +25% | +$13.6M | 1.37% | 26 |
|
|
2023
Q3 | $46.8M | Sell |
415,900
-73,100
| -15% | -$8.22M | 0.99% | 37 |
|
|
2023
Q2 | $46.1M | Hold |
489,000
| – | – | 0.84% | 44 |
|
|
2023
Q1 | $49.5M | Sell |
489,000
-198,700
| -29% | -$20.1M | 0.97% | 35 |
|
|
2022
Q4 | $82.1M | Sell |
687,700
-208,845
| -23% | -$24.9M | 1.57% | 17 |
|
|
2022
Q3 | $95.2K | Buy |
896,545
+47,000
| +6% | +$4.99K | 1.77% | 20 |
|
|
2022
Q2 | $82.8K | Sell |
849,545
-25,970
| -3% | -$2.53K | 1.5% | 25 |
|
|
2022
Q1 | $82.1M | Sell |
875,515
-56,400
| -6% | -$5.29M | 1.33% | 26 |
|
|
2021
Q4 | $79.4M | Sell |
931,915
-260,100
| -22% | -$22.2M | 1.02% | 34 |
|
|
2021
Q3 | $114M | Sell |
1,192,015
-39,100
| -3% | -$3.75M | 1.26% | 25 |
|
|
2021
Q2 | $120M | Sell |
1,231,115
-70,600
| -5% | -$6.87M | 1.21% | 27 |
|
|
2021
Q1 | $127M | Hold |
1,301,715
| – | – | 1.18% | 24 |
|
|
2020
Q4 | $125M | Hold |
1,301,715
| – | – | 1.09% | 24 |
|
|
2020
Q3 | $125M | Buy |
1,301,715
+115,800
| +10% | +$11.1M | 1.57% | 18 |
|
|
2020
Q2 | $145M | Buy |
1,185,915
+30,900
| +3% | +$3.77M | 2.04% | 18 |
|
|
2020
Q1 | $100M | Buy |
1,155,015
+219,045
| +23% | +$19M | 1.68% | 20 |
|
|
2019
Q4 | $101M | Sell |
935,970
-639,200
| -41% | -$68.7M | 1.44% | 20 |
|
|
2019
Q3 | $142M | Sell |
1,575,170
-258,030
| -14% | -$23.3M | 2.69% | 10 |
|
|
2019
Q2 | $155M | Hold |
1,833,200
| – | – | 2.4% | 9 |
|
|
2019
Q1 | $162M | Buy |
1,833,200
+1,339,000
| +271% | +$118M | 2.5% | 9 |
|
|
2018
Q4 | $35.3M | Buy |
494,200
+356,400
| +259% | +$25.5M | 0.65% | 50 |
|
|
2018
Q3 | $16.9M | Hold |
137,800
| – | – | 0.2% | 93 |
|
|
2018
Q2 | $13.5M | Buy |
137,800
+62,800
| +84% | +$6.17M | 0.16% | 104 |
|
|
2018
Q1 | $6.22M | Buy |
+75,000
| New | +$6.22M | 0.08% | 112 |
|
|
2017
Q4 | – | Sell |
-284,841
| Closed | -$17.5M | – | 136 |
|
|
2017
Q3 | $17.5M | Hold |
284,841
| – | – | 0.17% | 87 |
|
|
2017
Q2 | $13.1M | Sell |
284,841
-156,500
| -35% | -$7.2M | 0.14% | 92 |
|
|
2017
Q1 | $19.1M | Sell |
441,341
-1,687,433
| -79% | -$73.1M | 0.22% | 80 |
|
|
2016
Q4 | $82.4M | Buy |
2,128,774
+313,300
| +17% | +$12.1M | 1.05% | 32 |
|
|
2016
Q3 | $91.9M | Hold |
1,815,474
| – | – | 1.05% | 34 |
|
|
2016
Q2 | $82.5M | Sell |
1,815,474
-838,400
| -32% | -$38.1M | 0.86% | 41 |
|
|
2016
Q1 | $105M | Buy |
2,653,874
+138,900
| +6% | +$5.49M | 1.1% | 29 |
|
|
2015
Q4 | $142M | Sell |
2,514,974
-1,301,076
| -34% | -$73.6M | 1.29% | 25 |
|
|
2015
Q3 | $152M | Sell |
3,816,050
-1,278,450
| -25% | -$50.9M | 1.53% | 21 |
|
|
2015
Q2 | $243M | Sell |
5,094,500
-739,100
| -13% | -$35.3M | 2.03% | 17 |
|
|
2015
Q1 | $232M | Sell |
5,833,600
-135,000
| -2% | -$5.36M | 1.98% | 20 |
|
|
2014
Q4 | $133M | Buy |
5,968,600
+175,000
| +3% | +$3.91M | 1.27% | 31 |
|
|
2014
Q3 | $90.8M | Buy |
5,793,600
+1,117,900
| +24% | +$17.5M | 0.95% | 33 |
|
|
2014
Q2 | $69.4M | Sell |
4,675,700
-775,300
| -14% | -$11.5M | 0.81% | 39 |
|
|
2014
Q1 | $87.8M | Buy |
5,451,000
+2,820,000
| +107% | +$45.4M | 1.08% | 29 |
|
|
2013
Q4 | $24.6M | Buy |
2,631,000
+2,056,000
| +358% | +$19.2M | 0.36% | 56 |
|
|
2013
Q3 | $6.51M | Sell |
575,000
-193,000
| -25% | -$2.18M | 0.12% | 81 |
|
|
2013
Q2 | $10.3M | Buy |
+768,000
| New | +$10.3M | 0.22% | 68 |
|